Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting-Practice and Outcomes.

Abdo J, Bertellotti CA, Cornell DL, Agrawal DK, Mittal SK.

Open source

DOI
10.3389/fonc.2017.00151
Published
2017-07-18
Container
Front Oncol
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 18/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2017.00151,
  title = {Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting-Practice and Outcomes.},
  author = {Abdo J and  Bertellotti CA and  Cornell DL and  Agrawal DK and  Mittal SK.},
  year = {2017},
  journal = {Front Oncol},
  doi = {10.3389/fonc.2017.00151},
  url = {https://doi.org/10.3389/fonc.2017.00151}
}

RIS

TY  - JOUR
TI  - Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting-Practice and Outcomes.
AU  - Abdo J
AU  -  Bertellotti CA
AU  -  Cornell DL
AU  -  Agrawal DK
AU  -  Mittal SK.
PY  - 2017
JO  - Front Oncol
DO  - 10.3389/fonc.2017.00151
UR  - https://doi.org/10.3389/fonc.2017.00151
ER  - 

APA

J, A., CA, B., DL, C., DK, A., & SK., M. (2017). Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting-Practice and Outcomes.. Front Oncol. https://doi.org/10.3389/fonc.2017.00151

Source records